- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Mind Medicine Inc (MNMD)
Mind Medicine Inc stock price live, this page displays NASDAQ MNMD stock exchange data. View the MNMD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Mind Medicine Inc real time stock price chart below.
What Is the Mind Medicine Inc Stock Price Today?
The Mind Medicine Inc stock price today is 9.030.
What Is the Stock Symbol for Mind Medicine Inc?
The stock symbol for Mind Medicine Inc is ""MNMD.""
What Stock Exchange Does Mind Medicine Inc Trade On?
Mind Medicine Inc is listed and trades on the NASDAQ stock exchange.
Is Mind Medicine Inc a Good Stock to Buy?
Determining whether Mind Medicine Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MNMD quote. (ISIN: CA60255C8850)
What Is the Mind Medicine Inc Stock Price Today?
The Mind Medicine Inc stock price today is 9.030.
What Is the Stock Symbol for Mind Medicine Inc?
The stock symbol for Mind Medicine Inc is ""MNMD.""
What Stock Exchange Does Mind Medicine Inc Trade On?
Mind Medicine Inc is listed and trades on the NASDAQ stock exchange.
Is Mind Medicine Inc a Good Stock to Buy?
Determining whether Mind Medicine Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MNMD quote. (ISIN: CA60255C8850)
NASDAQ
Currency in USD
9.030
-0.110(-1.20%)
Closed·
After Hours
9.040+0.010(+0.11%)
·
Fair Value
An estimate of a Mind Medicine's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.940
9.440
52 wk Range
4.700
10.436
MNMD Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected tomorrow
More Info
Fair Value
An estimate of a Mind Medicine's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.9409.440
52 wk Range
4.70010.436
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MNMD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Mind Medicine's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
24.500
Upside
+171.32%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings upwards for the upcoming period
- MindMed Announces New Employee Inducement Grants
- Investing.com
- MindMed Announces New Employee Inducement Grants
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Mind Medicine Inc Company Profile
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company’s lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
Mind Medicine Inc SWOT Analysis
Breakthrough Therapy | MindMed's MM120, an LSD-based compound, shows promise in treating Generalized Anxiety Disorder with rapid onset and lasting effects |
Market Potential | Analysts project peak U.S. sales of $1.6 billion for MM120, with potential revenue reaching $2.29 billion by 2031 in the multi-billion-dollar GAD market |
Regulatory Landscape | FDA's Breakthrough Therapy Designation for MM120 could expedite development, reducing regulatory risks and attracting investor interest |
Financial Outlook | Analyst price targets range from $16 to $55, reflecting significant upside potential despite current unprofitability in this clinical-stage company |
Mind Medicine Inc Earnings Call Summary for Q1/2025
- MindMed's Q1 2025 EPS of -$0.35 missed forecast, but stock rose 4.44% to $6.6 pre-market
- R&D expenses increased to $23.4M from $11.7M in Q1 2024, focusing on Phase 3 trials for MM120 ODT
- Cash reserves of $245.5M extend runway to 2027; amended loan agreement provides access to $120M
- Company expects top-line data for MM120 ODT trials in 2026, targeting GAD and MDD treatments
- New CCO Matt Wiley expressed confidence in MM120 ODT's potential to address unmet needs for 50M+ in U.S.
Last Updated: 08/05/2025, 13:50
Read Full TranscriptCompare MNMD to Peers and Sector
Metrics to compare | MNMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMNMDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.8x | −0.5x | −0.5x | |
PEG Ratio | −0.14 | −0.01 | 0.00 | |
Price/Book | 3.1x | 2.8x | 2.6x | |
Price / LTM Sales | - | 2.2x | 3.2x | |
Upside (Analyst Target) | 118.8% | 179.0% | 42.0% | |
Fair Value Upside | Unlock | 22.9% | 6.6% | Unlock |
Analyst Ratings
10 Buy
0 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 24.500
(+171.32% Upside)
Earnings
Latest Release
May 08, 2025
EPS / Forecast
-0.35 / -0.34
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Mind Medicine Trade On?
Mind Medicine is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Mind Medicine?
The stock symbol for Mind Medicine is "MNMD."
What Is the Mind Medicine Market Cap?
As of today, Mind Medicine market cap is 681.11M.
What Is Mind Medicine's Earnings Per Share (TTM)?
The Mind Medicine EPS (TTM) is -0.97.
When Is the Next Mind Medicine Earnings Date?
Mind Medicine will release its next earnings report on 30 Jul 2025.
From a Technical Analysis Perspective, Is MNMD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Mind Medicine Stock Split?
Mind Medicine has split 1 times.
How Many Employees Does Mind Medicine Have?
Mind Medicine has 74 employees.
What is the current trading status of Mind Medicine (MNMD)?
As of 30 Jul 2025, Mind Medicine (MNMD) is trading at a price of 9.03, with a previous close of 9.14. The stock has fluctuated within a day range of 8.94 to 9.44, while its 52-week range spans from 4.70 to 10.44.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.